134 related articles for article (PubMed ID: 12485176)
1. Sensitivity and specificity of urine cytology in the screening of transitional cell carcinomas.
Keir JA; Womack C
Cytopathology; 2002 Dec; 13(6):381-2. PubMed ID: 12485176
[No Abstract] [Full Text] [Related]
2. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
Konety BR; Metro MJ; Melham MF; Salup RR
Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Advances in Urine Cytology.
Xing J; Reynolds JP
Surg Pathol Clin; 2018 Sep; 11(3):601-610. PubMed ID: 30190143
[TBL] [Abstract][Full Text] [Related]
4. [Urinary cytology of transitional-cell carcinoma].
Piazza G; Galia A; Cosentino A; Grasso G
Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
[TBL] [Abstract][Full Text] [Related]
5. Urinary cytology and the Paris system for reporting urinary cytology: Implications for urological management.
Gupta M; VandenBussche CJ; Bivalacqua TJ
Cytopathology; 2018 Aug; 29(4):368-370. PubMed ID: 29575439
[TBL] [Abstract][Full Text] [Related]
6. [Combined cytology/cytometry for preventing misinterpretations of urine cytology].
vom Dorp F
Urologe A; 2007 Sep; 46(9):1140-1. PubMed ID: 17665165
[No Abstract] [Full Text] [Related]
7. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine.
Renshaw AA; Nappi D; Weinberg DS
Acta Cytol; 1996; 40(4):676-82. PubMed ID: 8693885
[TBL] [Abstract][Full Text] [Related]
8. Urine cytology in bladder tumors.
Zein TA; Milad MF
Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
[TBL] [Abstract][Full Text] [Related]
9. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
13. [Urine cytology in the diagnosis of urothelium tumors].
Rona-Selnic G
Med Lab (Stuttg); 1982; 35(6):158-62. PubMed ID: 7162453
[No Abstract] [Full Text] [Related]
14. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
15. [Expression of the tumormarker p16INK4a in cytology specimens of the urinary bladder. A new means for early recognition and surveillance of urothelial cancer].
Tauber S; Brunken C; Vierbuchen M
Urologe A; 2011 Sep; 50(9):1130-3. PubMed ID: 21847682
[TBL] [Abstract][Full Text] [Related]
16. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
Al-Maghrebi M; Kehinde EO; Kapila K; Anim JT
Med Princ Pract; 2012; 21(3):295-7. PubMed ID: 22236881
[TBL] [Abstract][Full Text] [Related]
17. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.
Lotan Y; Roehrborn CG
Urology; 2003 Jan; 61(1):109-18; discussion 118. PubMed ID: 12559279
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
